GSK

GSK is the result of the merger of Glaxo Wellcome and SmithKline Beecham. It is also a biochemical research company and its products cover a large part in the pharmacy field, but some focus on the CNS, oncology, antibiotics, respiratory and endocrinology.

In 2014 GSK acquired the Novartis vaccine unit and Novartis the consumption unit (OTC) taking both control over them in March 2015.

According to the classification of Forbes magazine for 2014, GSK is the sixth largest pharmaceutical company in the world